Common TitleRUBY-I
Official Title Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease
Phase Phase III
ClinicalTrials.gov NCT02207088
Treatments
Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir
Ombitasvir-Paritaprevir-Ritonavir and Dasabuvir
Tradename:Viekira PakOther Names:3DClass:DiscontinuedFunding
IndustryAbbVie